期刊文献+

雌激素调节卵巢癌细胞增殖与分泌转化生长因子的关系

The change of the secretion of transforming growth factor-α,β_1 by estrogen on ovarian cancer HO-8910 cell line and its relationship with cell proliferation
下载PDF
导出
摘要 目的 观察不同浓度的 17 β雌二醇 (E2 )对人卵巢上皮性癌细胞株HO 8910及人皮肤成纤维细胞系增殖的抑制率与分泌转化生长因子 α、β1(TGF α、TGF β1)的关系。方法 取小儿包皮做人皮肤成纤维细胞的原代培养 ,用细胞增殖抑制实验 (MTT比色法 )检测在不同浓度的E2 作用下 ,HO 8910细胞与人皮肤成纤维细胞增殖的情况 ;用放免及酶标 (ELISA)方法检测同样条件下TGF α、TGF β1的分泌量。结果 HO 8910细胞在E2 作用下 ,细胞增殖明显受影响 ;成纤维细胞在同样处理下 ,无明显的受抑制作用 ;TGF α的分泌量与HO 8910细胞增殖呈正相关 ,TGF β1的分泌量与其呈负相关 ;两者的分泌量与成纤维细胞的增殖率无关。结论 HO 8910细胞存在TGF α、TGF β1的自分泌调节机制 ,在体外受到E2 的调节 ,该机制可能参与细胞的增殖调节。 Objective To investigate the regulatory effect of the secretion of transforming growth factor-α,β 1(TGF-α,TGF-β 1) by estrogen on ovarian cancer HO-8910 cell line,human fibroblast and on cell proliferation in vitro.Methods The cytotoxicities were assayed with MTT.The secretion of TGF-α was investigated using RIA kit.The secretion of TGF-β 1 was studied using TGF-β 1 human quantitative ELISA kit.Results Treated with 10 -5~10 -13 mol/L of E 2,the effect on human fibroblast cell line was not noticeoble,but E 2 inhibited the growth of HO-8910 cell line at high(10 -5 mol/L) and low(10 -12,10 -13 mol/L)concentration and promoted the cell proliferation obviously at 10 -9 and 10 -10 mol/L.The secretion of TGF-α decreased and the secretion of TGF-β 1 increased whether HO-8910 cell line was inhibited or not.Conclusion The effect of E 2 on HO-8910 cell line is great.E 2 may inhibit the cell proliferation by down-regulate the TGF-α autocrine and up-regulate the TGF-β 1 autocrine.E 2 has no effect on the proliferation of human fibroblast and the secretion of TGF-α,TGF-β 1.
作者 张焱 程云英
出处 《江苏医药》 CAS CSCD 北大核心 2004年第11期824-826,共3页 Jiangsu Medical Journal
  • 相关文献

参考文献7

  • 1[2]Langdon SP, Hirst GL, Miller EP, et al. The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell lines. J Steroid Biochem Mol Biol, 1994,50:131-135.
  • 2杨毅,沈铿,郎景和.雌激素对卵巢癌细胞株体外生长的影响[J].中华妇产科杂志,2000,35(3):172-174. 被引量:8
  • 3[4]Ueda M, Fujii H, Kumagai K, et al. Effecys of sex steroids and growth factors on invasive activity and 5 '-deoxy-5-fluorouridine sensitivity in ovarian adenocarcinoma OMC-3 cells. Jpn J Cancer Res, 1998,89 : 1334-1342.
  • 4[5]Stronberg K,Collins TJ,Gorlon AW,et al. Transforming growth factor-α acts as an autocrine growth factor in ovarian carcinoma cell line. Cancer Res, 1992,52: 341-347.
  • 5[6]Chien CH, Huang CC, Lin YH, et al. Detection of serum transforming growth factor-α in patients of primary epithelial ovarian cancers by enzyme immunoassay. Gynec Oncol, 1997, 66: 405-410.
  • 6[7]Simpson BJ, Langdon SP, Rabiasz GJ, et al. Estrogen regulation of transforming growth factor-alpha in ovarian cancer. J Steroid Biochem Mol Biol, 1998,64:137-145.
  • 7[8]Santin AD, Hermonat PL, Hiserodt JC, et al. Differential transforming growth factor-β secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix Gynec Oncol, 1997,64:477-480.

二级参考文献1

  • 1Eeles R A,BMJ,1991年,302期,259262页

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部